B

Binex Co Ltd
KOSDAQ:053030

Watchlist Manager
Binex Co Ltd
KOSDAQ:053030
Watchlist
Price: 15 410 KRW -4.23% Market Closed
Market Cap: 503.6B KRW

Binex Co Ltd
Investor Relations

BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Busan, Busan. The company went IPO on 2001-08-07. The Company’s products include digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as ointment, creams and others. The company also manufactures bio medicines and raw materials. The firm distributes its products within domestic market and to overseas markets.

Show more
Loading
053030
KOSPI 200
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

No Earnings Calls Available

Management

Won-Seok Kim
Head of Production Division and Director
No Bio Available
Young-Cheol Son
Head of Management Support Division and Director
No Bio Available
Jung-Jin Lee
Head of Bio-Tech Research Center and Director
No Bio Available
Byung-In Lee
Head of Bus. Operation Division and Director
No Bio Available
Jung-Won Seo
Head of Bio Processing Division and Director
No Bio Available
Mr. Hyuk-Jong Lee
Managing Director
No Bio Available
Doo-Hyun Kim
VP
No Bio Available
Jung-Tak Moon
Chief Exec. Officer
No Bio Available

Contacts

Address
BUSAN
BUSAN
368-3, Dadae-ro, Saha-gu
Contacts
+82328503000
www.bi-nex.co.kr
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.